You are here

Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC

GRACE Videos and Articles

Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.

November is Lung Cancer Awareness Month. What are you grateful for?

Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.

[powerpress]

Get more information about the IMpower-110 Trial and CheckMate-227 Trial.

[ratingwidget post_id=0]

Check out more LCAM videos & posts here.

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Community Forum

Odd finding on shoulder X-ray

Last Reply:

Thanks so much for the quick response. Hearing the line "large mass in your scapula with probable neoplastic properties" threw me through a loop. I really expected bursitis. I'm hopeful it's...

How long can a Pleurx chest catheter stay in place?

Last Reply:

I understand Joanne. There are a million different ways to get thrown into the deep end of lung cancer and there's only so much understanding you can take in or find...

8 weeks after starting Tagrisso

Last Reply:

I hope someone with experience will chime in. According to clinicians pleurex cath can be worn as long as it's functioning appropriately but at least several months.

PleurX catheter causing new pain

Last Reply:

Jonathan, Do you know if the nurse has tried draining less fluid? I don't know if you were able to read through the links. One of the problems with on and...

Mother diagnosed with adenocarcinoma - treatment options

Last Reply:

Hi Rowan, There is one active (but not currently recruiting) Phase I study testing the efficacy and safety of this combination: Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant...

Pancoast tumor

Last Reply:

Thanks Judy :)

Update

Last Reply:

I hate to hear that she isn't able to join the trial and hope she can save the chemo for later. I'll have to look up tarlox I'm not familiar but...

header share links

Logo

Main menu

You are here

Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC

Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC

Get more information about the IMpower-110 Trial and CheckMate-227 Trial.

Join the Conversation

Search form

Related Content

Community Forum